Stock listing
NYSE American:OGEN Oragenics Inc. Stock
Home listing (NYSE American) of Oragenics Inc.
Follow Oragenics Inc. into a list and get an email when it puts out news.
Share price · AMEX:OGEN
$0.374 USD -0.000 (-0.1%)
Close on Oct 30, 2026
- Day range
- $0.371 – $0.386 USDOct 30, 2026
- Volume
- 9,190 sharesOct 30, 2026
- Market cap
- $1.69M USDAt the close on Oct 30, 2026 · price × 4.51M shares outstanding
- 52-week range
- $0.351 – $1.230 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $14,247 USDMedian day 19,500 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:OGEN · Home | $0.374 USD | 0.000 (-0.1%) | 9,190 | $0.373 | $0.386 | $0.371 | $0.374 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:OGEN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.374 | 0.000 | -0.1% | $0.373 | $0.386 | $0.371 | 9,190 | |
| $0.374 | -0.006 | -1.5% | $0.376 | $0.381 | $0.373 | 5,993 | |
| $0.380 | +0.014 | +3.8% | $0.381 | $0.398 | $0.370 | 13,800 | |
| $0.366 | -0.033 | -8.2% | $0.384 | $0.384 | $0.351 | 62,428 | |
| $0.399 | -0.021 | -5.1% | $0.410 | $0.410 | $0.399 | 16,220 | |
| $0.420 | +0.010 | +2.4% | $0.410 | $0.420 | $0.400 | 9,400 | |
| $0.410 | 0.000 | 0.0% | $0.410 | $0.410 | $0.400 | 20,400 | |
| $0.410 | -0.020 | -4.7% | $0.440 | $0.440 | $0.410 | 5,300 | |
| $0.430 | +0.010 | +2.4% | $0.440 | $0.450 | $0.410 | 14,800 | |
| $0.420 | -0.010 | -2.3% | $0.440 | $0.450 | $0.420 | 36,000 | |
| $0.430 | -0.010 | -2.3% | $0.450 | $0.450 | $0.430 | 32,700 | |
| $0.440 | 0.000 | 0.0% | $0.430 | $0.460 | $0.430 | 11,600 | |
| $0.440 | -0.010 | -2.2% | $0.450 | $0.450 | $0.430 | 16,900 | |
| $0.450 | 0.000 | 0.0% | $0.450 | $0.450 | $0.440 | 16,300 | |
| $0.450 | -0.010 | -2.2% | $0.460 | $0.460 | $0.450 | 17,200 | |
| $0.460 | 0.000 | 0.0% | $0.470 | $0.480 | $0.450 | 28,200 | |
| $0.460 | -0.040 | -8.0% | $0.500 | $0.500 | $0.460 | 45,800 | |
| $0.500 | +0.010 | +2.0% | $0.500 | $0.500 | $0.490 | 11,600 | |
| $0.490 | 0.000 | 0.0% | $0.490 | $0.490 | $0.480 | 12,300 | |
| $0.490 | 0.000 | 0.0% | $0.480 | $0.500 | $0.480 | 42,300 | |
| $0.490 | +0.010 | +2.1% | $0.480 | $0.500 | $0.480 | 15,400 | |
| $0.480 | -0.010 | -2.0% | $0.490 | $0.520 | $0.480 | 32,400 | |
| $0.490 | +0.010 | +2.1% | $0.480 | $0.500 | $0.470 | 14,400 | |
| $0.480 | +0.010 | +2.1% | $0.490 | $0.490 | $0.460 | 42,000 | |
| $0.470 | -0.020 | -4.1% | $0.510 | $0.510 | $0.460 | 33,300 | |
| $0.490 | -0.010 | -2.0% | $0.520 | $0.520 | $0.480 | 11,800 | |
| $0.500 | +0.010 | +2.0% | $0.490 | $0.500 | $0.490 | 17,400 | |
| $0.490 | -0.030 | -5.8% | $0.520 | $0.530 | $0.490 | 40,000 | |
| $0.520 | 0.000 | 0.0% | $0.520 | $0.530 | $0.500 | 25,300 | |
| $0.520 | +0.040 | +8.3% | $0.480 | $0.520 | $0.480 | 37,900 | |
| $0.480 | -0.040 | -7.7% | $0.500 | $0.520 | $0.480 | 43,000 | |
| $0.520 | +0.020 | +4.0% | $0.500 | $0.520 | $0.490 | 48,900 | |
| $0.500 | +0.010 | +2.0% | $0.500 | $0.520 | $0.480 | 54,500 | |
| $0.490 | -0.010 | -2.0% | $0.490 | $0.500 | $0.480 | 25,200 | |
| $0.500 | +0.020 | +4.2% | $0.480 | $0.500 | $0.480 | 23,500 | |
| $0.480 | -0.020 | -4.0% | $0.500 | $0.500 | $0.480 | 66,900 | |
| $0.500 | -0.020 | -3.8% | $0.510 | $0.510 | $0.500 | 9,200 | |
| $0.520 | 0.000 | 0.0% | $0.520 | $0.520 | $0.510 | 4,700 | |
| $0.520 | +0.010 | +2.0% | $0.510 | $0.520 | $0.510 | 12,600 | |
| $0.510 | +0.010 | +2.0% | $0.500 | $0.520 | $0.500 | 8,300 | |
| $0.500 | -0.010 | -2.0% | $0.510 | $0.520 | $0.500 | 22,900 | |
| $0.510 | +0.010 | +2.0% | $0.510 | $0.530 | $0.500 | 25,300 | |
| $0.500 | -0.010 | -2.0% | $0.500 | $0.520 | $0.500 | 16,100 | |
| $0.510 | -0.010 | -1.9% | $0.520 | $0.530 | $0.490 | 101,200 | |
| $0.520 | -0.010 | -1.9% | $0.530 | $0.530 | $0.520 | 73,800 | |
| $0.530 | 0.000 | 0.0% | $0.530 | $0.540 | $0.510 | 29,600 | |
| $0.530 | +0.010 | +1.9% | $0.540 | $0.540 | $0.520 | 7,200 | |
| $0.520 | 0.000 | 0.0% | $0.510 | $0.530 | $0.510 | 12,900 | |
| $0.520 | -0.010 | -1.9% | $0.520 | $0.530 | $0.510 | 30,400 | |
| $0.530 | -0.010 | -1.9% | $0.530 | $0.540 | $0.520 | 56,400 | |
| $0.540 | +0.010 | +1.9% | $0.550 | $0.550 | $0.530 | 16,000 | |
| $0.530 | -0.020 | -3.6% | $0.550 | $0.560 | $0.530 | 11,000 | |
| $0.550 | +0.010 | +1.9% | $0.540 | $0.560 | $0.530 | 40,300 | |
| $0.540 | +0.010 | +1.9% | $0.540 | $0.570 | $0.530 | 197,900 | |
| $0.530 | 0.000 | 0.0% | $0.540 | $0.540 | $0.530 | 6,800 | |
| $0.530 | -0.010 | -1.9% | $0.530 | $0.540 | $0.530 | 4,700 | |
| $0.540 | -0.010 | -1.8% | $0.520 | $0.550 | $0.520 | 13,600 | |
| $0.550 | 0.000 | 0.0% | $0.520 | $0.550 | $0.510 | 31,000 | |
| $0.550 | 0.000 | 0.0% | $0.550 | $0.570 | $0.500 | 33,100 | |
| $0.550 | +0.010 | +1.9% | $0.550 | $0.550 | $0.540 | 13,900 | |
| $0.540 | 0.000 | 0.0% | $0.540 | $0.550 | $0.540 | 18,600 | |
| $0.540 | -0.010 | -1.8% | $0.540 | $0.560 | $0.530 | 13,500 | |
| $0.550 | +0.020 | +3.8% | $0.520 | $0.560 | $0.490 | 23,300 | |
| $0.530 | +0.030 | +6.0% | $0.500 | $0.530 | $0.500 | 42,800 | |
| $0.500 | +0.010 | +2.0% | $0.510 | $0.510 | $0.490 | 41,600 | |
| $0.490 | -0.010 | -2.0% | $0.500 | $0.500 | $0.480 | 15,900 |
- Ticker
- NYSE American:OGEN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · May 19, 2026
Investor Presentation - May 2026
Latest deck · Sep 16, 2026
IPAC-RS Successful Studies Case (September 2026)
Conference · 21 slides
Latest news
Investor Presentation - May 2026
May 19, 2026
Closed $0.57 (0.0%) on May 19, 2026
Oragenics provides investor update
May 18, 2026
Closed $0.57 (-3.4%) on May 18, 2026
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
May 7, 2026
Closed $0.61 (-1.6%) on May 7, 2026
Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.
May 5, 2026
Closed $0.64 (+3.2%) on May 5, 2026
Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
Apr 20, 2026
Closed $0.71 (-1.4%) on Apr 20, 2026
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
Mar 25, 2026
Closed $0.58 (-6.5%) on Mar 26, 2026
Oragenics files annual report on Form 10-K
Mar 17, 2026
Closed $0.78 (-2.5%) on Mar 17, 2026
Oragenics initiates Phase IIa clinical trial site activation
Mar 12, 2026
Closed $0.96 (+9.1%) on Mar 12, 2026
Oragenics explores expansion of CNS platform pursuing acquistion of assets in brain health, recovery, and neuroprotection
Mar 11, 2026
Closed $0.88 (-10.2%) on Mar 11, 2026
Decks
IPAC-RS Successful Studies Case (September 2026)
Conference · 21 slides · Sep 16, 2026
Investor Presentation (May 2026)
Investor deck · 15 slides · May 2026
Investor Presentation (January 2026)
Investor deck · 17 slides · Jan 20, 2026
Corporate Update (May 2025)
Corporate update · 28 slides · May 20, 2025
Oragenics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 29 in all · newest May 19, 2026 · oldest 2025
- Decks
- 28 decks · latest Sep 16, 2026
Where Oragenics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:OGEN · Home listing · This page | NYSE American | United States | USD |
| BOATS:OGEN | BOATS | United States | USD |
| gettex:UAV0 | gettex | Germany | EUR |
| LSE:0A64 | LSE | United Kingdom | USD |
| Munich:UAV0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Oragenics Inc.